John Esther
@johnesthermd
MD
ID: 1078753438777786368
28-12-2018 20:43:56
7 Tweet
53 Followers
47 Following
John Esther, a PGY2 University of Utah Health resident, presenting a GWAS of mPCa at #GU19 Neeraj Agarwal, MD, FASCO Caroline Milne
Just out in European Urology - Umang Swami, MD, MSCI, FASCO Huntsman Cancer Institute (mentored by Neeraj Agarwal, MD, FASCO) works with Emmanuel Antonarakis AjjaiAlva Ulka Vaishampayan Andy Hahn Benjamin L Maughan to demonstrate that mtSPOP confers superior PFS/OS in mCSPC (prev shown in mCRPC). Full article at: sciencedirect.com/science/articl…
Sumanta K. Pal, MD, FASCO European Urology Umang Swami, MD, MSCI, FASCO Huntsman Cancer Institute Emmanuel Antonarakis AjjaiAlva Ulka Vaishampayan Andy Hahn Benjamin L Maughan @NeliMUlrich Toni Choueiri, MD PCF Science Prostate Cancer Foundation Tanya Dorff Michigan Urology Johns Hopkins Kimmel Cancer Center Nima Sharifi chadi nabhan MD, MBA, FACP Andrey Soares Thanks Sumanta K. Pal, MD, FASCO In a multivariate analysis, SPOP mutation conferred improved outcomes in men with denovo metastatic castration sensitive #prostatecancer . Wonderful collaborative effort, external validation in process. European Urology
Our study in Clinical Cancer Research today: 1st report from a federally funded prospective trial (SWOG Cancer Research Network S1216) in new metastatic #prostatecancer (mCSPC)👉showing tremendous negative impact of baseline CTCs on survival outcomes👇These men need novel trials bit.ly/3ojNWst OncoAlert
ASCO #GU21 is underway and 1st year fellows John Esther and Haoran Li are representing 💪: 👉⬆️baseline CTC counts in mCSPC associated with inferior survival outcomes meetinglibrary.asco.org/record/194906/… GU Cancer Research Program @HuntsmanCancer Umang Swami, MD, MSCI, FASCO Neeraj Agarwal, MD, FASCO Andy Hahn